S J Schwab1, G Beathard. 1. Duke University Medical Center, Durham, North Carolina, USA.
Abstract
BACKGROUND: Hemodialysis requires reliable recurrent access to the circulation. On a chronic basis, this has been best provided by the use of arteriovenous fistulae and arteriovenous grafts. In recent years, hemodialysis catheters have come to play an increasingly important role in the delivery of hemodialysis. The use of both temporary as well as cuffed hemodialysis catheters has emerged as a significant boon for both patients and practicing nephrologists. The complications, however, associated with each of these hemodialysis catheters, both in terms of anatomic, thrombotic, and infectious issues, have emerged as a major problem with their continued use. This significant morbidity and complication rate has forced many nephrologists to face a basic conundrum: they have come to hate having to deal with the problems inherent in catheter usage, but the enormous utility of these devices have forced physicians to accept the fact they cannot live without them in their current practice. METHODS: We used a comprehensive literature review to describe the types, use and dilemmas of hemodialysis catheters. RESULTS: This article provides a comprehensive review of both the benefits inherent with the use of these hemodialysis catheters while cataloging their complications and offering some possible solutions. CONCLUSION: Hemodialysis vascular access catheters are essential in the maintenance of hemodialysis vascular access. However, they have a significant infectious, thrombotic, anatomic complication rate that are detailed with proposed problem-solving guidelines.
BACKGROUND: Hemodialysis requires reliable recurrent access to the circulation. On a chronic basis, this has been best provided by the use of arteriovenous fistulae and arteriovenous grafts. In recent years, hemodialysis catheters have come to play an increasingly important role in the delivery of hemodialysis. The use of both temporary as well as cuffed hemodialysis catheters has emerged as a significant boon for both patients and practicing nephrologists. The complications, however, associated with each of these hemodialysis catheters, both in terms of anatomic, thrombotic, and infectious issues, have emerged as a major problem with their continued use. This significant morbidity and complication rate has forced many nephrologists to face a basic conundrum: they have come to hate having to deal with the problems inherent in catheter usage, but the enormous utility of these devices have forced physicians to accept the fact they cannot live without them in their current practice. METHODS: We used a comprehensive literature review to describe the types, use and dilemmas of hemodialysis catheters. RESULTS: This article provides a comprehensive review of both the benefits inherent with the use of these hemodialysis catheters while cataloging their complications and offering some possible solutions. CONCLUSION: Hemodialysis vascular access catheters are essential in the maintenance of hemodialysis vascular access. However, they have a significant infectious, thrombotic, anatomic complication rate that are detailed with proposed problem-solving guidelines.
Authors: Douglas M Silverstein; Scott O Trerotola; Timothy Clark; Garth James; Wing Ng; Amy Dwyer; Marius C Florescu; Roman Shingarev; Stephen R Ash Journal: Clin J Am Soc Nephrol Date: 2018-10-11 Impact factor: 8.237
Authors: Rana S Hamid; Anupam K Kakaria; Saif A Khan; Saja Mohammed; Rashid Al-Sukaiti; Dawood Al-Riyami; Yasser W Al-Mula Abed Journal: Sultan Qaboos Univ Med J Date: 2015-11-23
Authors: Susan M McCormick; Justin T Seil; David S Smith; Francis Tan; Francis Loth Journal: Cardiovasc Eng Technol Date: 2012-09-11 Impact factor: 2.495
Authors: Jin Suk Kang; Hee Ryeong Jang; Jeong Eun Lee; Young Joo Park; Harin Rhee; Eun Young Seong; Ihm Soo Kwak; Il Young Kim; Dong Won Lee; Soo Bong Lee; Sang Heon Song Journal: Clin Exp Nephrol Date: 2015-07-30 Impact factor: 2.801
Authors: Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson Journal: BMC Nephrol Date: 2009-08-20 Impact factor: 2.388